title: A way forward on the medically appropriate use of white cell growth factors.
authors.affiliation: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287-0005, USA. tsmit136@jhmi.edu
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Smith
authors.forename: Bruce E
authors.initials: BE
authors.lastname: Hillner
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D018572:Disease-Free Survival; D019317:Evidence-Based Medicine; D005260:Female; D005500:Follow-Up Studies; D005544:Forecasting; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000191:economics / Q000639:trends*; D006801:Humans; D008297:Male; D020714:Maximum Tolerated Dose; D009369:Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy*; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D016184:Receptors, Colony-Stimulating Factor / Q000008:administration & dosage*; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D016184:Receptors, Colony-Stimulating Factor